The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 12, 2023

Filed:

May. 24, 2017
Applicants:

The University of Queensland, Queensland, AU;

The Provost, Fellows, Foundation Scholars, and the Other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth Near Dublin, Dublin, IE;

Inventors:

Luke O'Neill, Dublin, IE;

Rebecca Coll, West End, AU;

Matthew Cooper, Chapel Hill, AU;

Avril Robertson, Kenmore, AU;

Kate Schroder, Fairfield, AU;

Angus Murray MacLeod, Cambridge, GB;

David John Miller, Cambridge, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 311/60 (2006.01); C07D 495/04 (2006.01); C07D 207/38 (2006.01); C07D 217/24 (2006.01); C07D 241/24 (2006.01); C07D 249/04 (2006.01); C07D 261/18 (2006.01); C07D 271/12 (2006.01); C07D 307/68 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); C07C 311/60 (2013.01); C07D 207/38 (2013.01); C07D 217/24 (2013.01); C07D 241/24 (2013.01); C07D 249/04 (2013.01); C07D 261/18 (2013.01); C07D 271/12 (2013.01); C07D 307/68 (2013.01); C07D 413/12 (2013.01);
Abstract

The present invention relates to compounds of formula (I): wherein Q is O or S; Ris a cyclic group substituted with at least one group X, wherein Rmay optionally be further substituted; X is any group comprising a carbonyl group; and Ris a cyclic group substituted at the α-position, wherein Rmay optionally be further substituted. The present invention further relates to salts, solvates and prodrugs of such compounds, to pharmaceutical compositions comprising such compounds, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by the dual action of NLRPinhibition and the stimulation of insulin secretion.


Find Patent Forward Citations

Loading…